Recombinant Bevacizumab anticorps
MALS verified
Reactivité: Humain
Hôte: Souris
Monoclonal
AY10
unconjugated
Recombinant Antibody
-
- Antigène Tous les produits Bevacizumab
- Bevacizumab
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp Bevacizumab est non-conjugé
- Fonction
- Anti-Bevacizumab Antibody (AY10) (MALS verified, recommended for PK/PD)
- Attributs du produit
- Anti-idiotypic Antibodies
- Classe de qualité
- MALS verified
- Immunogène
- Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Bevacizumab F(ab')2.
- Clone
- AY10
-
-
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Stock
- -20 °C
-
- Antigène
- Bevacizumab
- Abstract
- Bevacizumab Produits
- Classe de substances
- Antibody
- Sujet
- A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.
-
Vous êtes ici:
